Clinical trial
Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in…
NCT00470925 · Institute for Neurodegenerative Disorders, Other · Terminated
Key facts
| NCT number | NCT00470925 |
|---|---|
| Title | Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects |
| Official title | Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects |
| Acronym | mZINT |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | Molecular NeuroImaging |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | 123-I MZINT injection and SPECT imaging |
| Enrollment | 30 |
| Start date | May 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | May 8, 2007 |
| Last update posted | Apr 3, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: